期刊文献+

葛根素抑制软脂酸诱导的小鼠3T3-L1细胞炎性因子的表达及其机制 被引量:4

Inhibition effect of puerarin on the expression of inflammatory factors in 3T3-L1 cells induced by palmitic acid and its mechanism in mice
原文传递
导出
摘要 目的探讨葛根素对小鼠3T3-L1细胞炎性因子的表达及其机制。方法用200μmol·L^(-1)软脂酸(PA)诱导小鼠3T3-L1成熟脂肪细胞成Toll样受体4(TLR4)介导的炎性细胞模型。将细胞分为4组:对照组(未经PA诱导的3T3-L1脂肪细胞)、模型组和低、高2个剂量实验组(葛根素5,10μmol·L^(-1))。用RT-PCR技术检测各组TLR4 mRNA表达,用酶联免疫吸附法检测各组细胞培养液中肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)水平,以免疫印迹法检测核因子κB激酶抑制剂β(IKKβ)、核因子κB抑制蛋白(IκB)及核因子κB-p65(NF-κB-p65)蛋白表达。结果对照组与模型组的TLR4 mRNA分别为1.20±0.20,6.23±0.80;这2组的TNF-α水平分别为(20.40±2.0),(60.20±8.0)pg·m L^(-1);这2组的IL-6表达水平分别为(4.20±0.2),(14.40±0.4)pg·m L^(-1),模型组与正常组的这3个指标比较,差异均有统计学意义(均P<0.01)。低、高2个剂量实验组的这3个指标分别为4.80±0.60和(38.80±6.0),(35.60±5.0)pg·m L^(-1);3.56±0.50和(8.80±0.5),(6.56±0.4)pg·m L^(-1),低、高2个剂量实验组与模型组比较,差异均有统计学意义(P<0.05,P<0.01)。模型组的IKKβ、IκB、NF-κB-p65蛋白相对表达水平分别为2.10±0.4,4.20±0.5,5.50±0.2;高剂量实验组的这3个指标分别为1.40±0.3,2.10±0.4,3.60±0.6,高剂量实验组与模型组相比,差异均有统计学意义(均P<0.01)。结论高剂量葛根素可抑制PA诱导的3T3-L1细胞炎性因子的表达,其机制可能是通过减少3T3-L1细胞TLR4基因表达、下调IKKβ、IκB、NF-κB-p65活化并降低TNF-α、IL-6炎性因子表达来实现的。 Objective To explore the effect and mechanism of puerarin on inflammatory response in murine 3 T3-L1 adipocytes. Methods Tolllike receptor 4( TLR4) mediated inflammatory cell models were based on palmitic acid( PA) 200 μmol·L^-1 stimulated 3 T3-L1 adipocytes cells. And then,these cells were divided into 4 groups: control group( without PA induction in 3 T3-L1 cells),model group,low and high dose experimental groups( 5,10 μmol · L^-1 puerarin). The mRNA expression of TLR4 was detected by Real-time PCR. The tumor necrosis factor α( TNF-α) and interleukin-6( IL-6) were performed using enzyme-linked immuno sorbent assay. The protein expressions of inhibitor of nuclear factor kappa-B kinase β( IKKβ),nuclear factor kappa Binhibitory protein( IκB),nuclear factor kappa B-p65( NF-κB p65) in 3 T3-L1 adipocytes cells were assessed by Western blot. Results The mRNA expression of TLR4 in control group and model group were 1. 20 ± 0. 20,6. 23 ± 0. 80; the level of TNF-α in the two groups were( 20. 40 ± 2. 0),( 60. 20 ± 8. 0) pg·m L^-1; the level of IL-6 in the two groups were( 4. 20 ± 0. 2),( 14. 40 ± 0. 4) pg·m L^-1. Comparison between control group and model group,the differnce on the three factors had significantly( all P〈0. 01). Meanwhile,after administration of puerarin,the protein expressions of IKKβ,IκB and NF-κ-p65 in model group were 2. 10 ± 0. 4,4. 20 ± 0. 5,5. 50 ± 0. 2; that in experimental-H group were 1. 40 ± 0. 3,2. 10 ± 0. 4,3. 60 ± 0. 6. Comparison between experimental-H group and model group,the differnce on the three factors had significantly( all P〈0. 01). Conclusion Experimental-H group attenuates palmitate-induced inflammatory response in 3 T3-L1 adipocytes,its underlying mechanism include inhibiting expression of TLR4 and downregulating activation of IKKβ,IκB,NF-κB-p65 and decreased expression of TNF-α,IL-6 levels.
作者 王小康 许耿瑞 吴铁松 刘江红 谢展雄 WANG Xiao - kang, XU Geng - rui, WU Tie - song, LIU Jiang - hong, XIE Zhan - xiong(Department of Pharmacy, Shenzhen Longhua District Central Hospital, Shenzhen Shenzhen 518110, Gunagdong Province, Chin)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2018年第9期1077-1080,共4页 The Chinese Journal of Clinical Pharmacology
基金 广东省科技计划基金资助项目(2009B030801031) 深圳市龙华新区科技创新基金资助项目(20160523A1030149)
关键词 葛根素 软脂酸 脂肪细胞 TOLL样受体4 炎性细胞因子 puerarin palmitic acid adipocyte Toll - like receptor 4 inflammatary cytokin
  • 相关文献

参考文献1

二级参考文献11

  • 1程斯倩,陈雪,于馨洋,李海雪,郭二勤,张赫,刘欢,李宗洲,赵丽晶.葛根异黄酮药理作用的研究进展[J].吉林医药学院学报,2013,34(1):46-49. 被引量:27
  • 2郑皓,王晓静.葛根的药理作用研究概况[J].光明中医,2006,21(3):49-51. 被引量:56
  • 3张迅轶,刘厚奇.脂肪细胞分化相关转录因子的结构和功能[J].生命科学,2007,19(2):194-197. 被引量:2
  • 4Lefterova M I, Lazar M A. New developments in adipogenesis[J]. Trends Endocrinol Metab, 2009, 20(3): 107-114.
  • 5Watanabe Y, Nagai Y, Takatsu K. Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance[J]. Nutrients, 2013, 5(9): 3757-3778.
  • 6Vidovic D, Busby S A, Griffin P R, et al. A combined ligand-and structure-based virtual screening protocol identifies submicromolar PPARγ partial agonists[J]. Chem Med Chem, 2011, 6(1): 94-103.
  • 7Sohn Y S, Park C, Lee Y, et al. Multi-conformation dynamic pharmacophore modeling of the peroxisome proliferator-activated receptor γ for the discovery of novel agonists[J]. J Mol Graph Model, 2013, 46C: 1-9.
  • 8Dunn F L, Higgins L S, Fredrickson J, et al. Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes[J]. J Diabetes Complications, 2011, 25(3): 151-158.
  • 9Lu C J, Sun Y, Muo C H, et al. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study[J]. Cerebrovasc Dis, 2013, 36(2): 145-151.
  • 10Ali A T, Hochfeld W E, Myburgh R, et al. Adipocyte and adipogenesis[J]. Eur J Cell Biol, 2013, 92(6/7): 229-236.

共引文献18

同被引文献113

引证文献4

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部